Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

YING VANG

Allopathic & Osteopathic Physicians Family Medicine

NPI
1861804569
CMS profile
1099600
Location
NEWTON, NC

General Payments · PY2018–2024

$2,522.54

  • Reported across 175 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$292.51

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $292.51 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $342.08 30
PY2019 $266.31 20
PY2020 $271.62 24
PY2021 $538.45 36
PY2022 $516.88 32
PY2023 $294.69 17
PY2024 $292.51 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.83 03/05/2024 Food and Beverage Undisputed 01/23/2026 1106270018 CMS
Amgen Inc. $16.02 11/19/2024 Food and Beverage Undisputed 01/23/2026 1116191538 CMS
Astellas Pharma US Inc $13.86 02/02/2024 Food and Beverage Undisputed 01/23/2026 1139278416 CMS
AstraZeneca Pharmaceuticals LP $16.74 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105584920 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.55 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086132888 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.33 07/09/2024 Food and Beverage Undisputed 01/23/2026 1118197650 CMS
GlaxoSmithKline, LLC. $19.51 01/11/2024 Food and Beverage Undisputed 01/23/2026 1115828565 CMS
Novo Nordisk Inc $14.27 02/08/2024 Food and Beverage Undisputed 01/23/2026 1096953554 CMS
Novo Nordisk Inc $14.48 05/01/2024 Food and Beverage Undisputed 01/23/2026 1096821718 CMS
Novo Nordisk Inc $14.55 10/23/2024 Food and Beverage Undisputed 01/23/2026 1097492240 CMS
Otsuka America Pharmaceutical, Inc. $25.81 05/10/2024 Food and Beverage Undisputed 01/23/2026 1118998113 CMS
PFIZER INC. $14.14 03/20/2024 Food and Beverage Undisputed 01/23/2026 1131564447 CMS
PFIZER INC. $21.24 05/30/2024 Food and Beverage Undisputed 01/23/2026 1131611913 CMS
PFIZER INC. $20.77 08/29/2024 Food and Beverage Undisputed 01/23/2026 1131842164 CMS
PFIZER INC. $15.24 11/07/2024 Food and Beverage Undisputed 01/23/2026 1132086294 CMS
SANOFI-AVENTIS U.S. LLC $20.17 01/24/2024 Food and Beverage Undisputed 01/23/2026 1139920082 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.